| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nurix Therapeutics, Inc. (NRIX) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. NRIX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 125.2K | $3.16M | -3,847 | |
| Other | 122.8K | $3.10M | -20,436 | |
| Dir | 50.0K | $1.26M | - | |
| CFO | 40.2K | $1.01M | -7,606 | |
| Dir | 10.8K | $271.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2024 | Hansen Gwenn72 | Chief Scientific Officer | Sale+OE | 3,408 | $20.67 | $70,435.52 | -7.0% | +27.3% | -42.8% | |
| Jul 30, 2024 | Ring Christine77 | Chief Legal Officer | Sale+OE | 2,920 | $20.67 | $60,349.68 | -10.6% | +27.3% | -42.8% | |
| Jul 30, 2024 | Van Houte Hans60 | Chief Financial Officer | Sale+OE | 2,490 | $20.67 | $51,462.57 | -4.4% | +27.3% | -42.8% | |
| Jul 1, 2024 | Ring Christine77 | Chief Legal Officer | Sale+OE | 5,760 | $20.81 | $119,836.89 | -12.5% | +7.5% | -44.0% | |
| Jun 20, 2024 | Van Houte Hans60 | Chief Financial Officer | Sell | 20,000 | $20.01 | $400,216.00 | -29.3% | +18.0% | -45.2% | |
| Jun 13, 2024 | Ring Christine77 | Chief Legal Officer | Sale+OE | 1,864 | $17.02 | $31,721.18 | -8.6% | +42.1% | -28.7% | |
| Jun 12, 2024 | Ring Christine77 | Chief Legal Officer | Sale+OE | 1,900 | $17.01 | $32,319.00 | -8.7% | +48.0% | -27.5% | |
| Jun 5, 2024 | Ring Christine77 | Chief Legal Officer | Sale+OE | 400 | $17.00 | $6,801.00 | -2.0% | +47.4% | -25.9% | |
| Jun 3, 2024 | Ring Christine77 | Chief Legal Officer | Sale+OE | 1,596 | $17.01 | $27,152.91 | -7.4% | +54.9% | -24.7% | |
| May 2, 2024 | Van Houte Hans60 | Chief Financial Officer | Sell | 3,499 | $12.83 | $44,878.17 | -4.9% | +71.9% | -11.5% |